A mobile app for improving the compliance with remote management of patients with cardiac implantable devices: a multicenter evaluation in clinical practice.

Autor: Lavalle C; Department of Cardiovascular, Respiratory, Nephrology, Anaesthesiology and Geriatric Sciences, Sapienza University of Rome, Viale del Policlinico, Rome, 00161, Italy., Magnocavallo M; Department of Cardiovascular, Respiratory, Nephrology, Anaesthesiology and Geriatric Sciences, Sapienza University of Rome, Viale del Policlinico, Rome, 00161, Italy. michelefg91@gmail.com., Bernardini A; Department of Cardiovascular, Respiratory, Nephrology, Anaesthesiology and Geriatric Sciences, Sapienza University of Rome, Viale del Policlinico, Rome, 00161, Italy., Vetta G; Department of Cardiovascular, Respiratory, Nephrology, Anaesthesiology and Geriatric Sciences, Sapienza University of Rome, Viale del Policlinico, Rome, 00161, Italy., Bianchi V; Unità Operativa di Elettrofisiologia, Studio e Terapia delle Aritmie, Monaldi Hospital, Naples, Italy., Mattera A; S. Anna e S. Sebastiano Hospital, Caserta, Italy., Mariani MV; Department of Cardiovascular, Respiratory, Nephrology, Anaesthesiology and Geriatric Sciences, Sapienza University of Rome, Viale del Policlinico, Rome, 00161, Italy., Ammendola E; Second University of Naples, A.O. Monaldi, Naples, Italy., Busacca G; Ospedale E. Muscatello, Augusta, Italy., Piro A; Department of Cardiovascular, Respiratory, Nephrology, Anaesthesiology and Geriatric Sciences, Sapienza University of Rome, Viale del Policlinico, Rome, 00161, Italy., Adduci C; Division of Cardiology, Department of Clinical and Molecular Medicine, Sapienza University of Rome, St. Andrea Hospital, Rome, Italy., Calò L; Policlinico Casilino, Rome, Italy., Panchetti L; Scuola Superiore Sant'Anna and Fondazione Toscana Gabriele Monasterio, Pisa, Italy., Viani S; University Hospital of Pisa, Pisa, Italy., Rapacciuolo A; Policlinico Federico II, Naples, Italy., Sanna G; P.O. San Martino, Oristano, Italy., Molon G; Sacro Cuore-Don Calabria Hospital, Verona, Italy., Quartieri F; Arrhythmology Centre, Arcispedale S. Maria Nuova, Reggio Emilia, Italy., Di Rosa R; Ospedale Santa Maria Goretti, Latina, Italy., Campari M; Boston Scientific, Milan, Italy., Valsecchi S; Boston Scientific, Milan, Italy., D'Onofrio A; Unità Operativa di Elettrofisiologia, Studio e Terapia delle Aritmie, Monaldi Hospital, Naples, Italy.
Jazyk: angličtina
Zdroj: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing [J Interv Card Electrophysiol] 2022 Jun; Vol. 64 (1), pp. 257-264. Date of Electronic Publication: 2022 Apr 12.
DOI: 10.1007/s10840-022-01207-y
Abstrakt: Background: The remote device management (RM) is recommended for patients with cardiac implantable electronic devices (CIEDs). RM underutilization is frequently driven by the lack of correct system activation. The MyLATITUDE Patient App (Boston Scientific) has been developed to encourage patient compliance with RM by providing information on communicator setup, troubleshooting, and connection status of the communicator.
Methods: At 14 centers, patients with CIEDs were invited to download and install the App on a mobile device. After 3 months, patients were asked to complete an ad hoc questionnaire to evaluate their experience.
Results: The App was proposed to 242 consecutive patients: 81 before RM activation, and 161 during follow-up. The App was successfully installed by 177 (73%) patients. The time required for activation of the communicator and the need for additional support were similar between patients who followed the indications provided by the App and those who underwent standard in-clinic training. During follow-up, notifications of lack of connection were received by 20 (11%) patients and missed transmission by 22 (12%). The median time from notification to resolution was 2 days. After 3 months, 175 (99%) communicators of the 177 patients who installed the App were in "Monitored" status versus 113 (94%) of 120 patients without the App installed (p=0.033). The use of the app made 84% of patients feel reassured.
Conclusions: The App was well accepted by CIED patients and offered support for communicator management and installation. Its use enabled patients to remain connected with greater continuity during follow-up.
(© 2022. The Author(s).)
Databáze: MEDLINE
Externí odkaz: